Notice: This CMS-approved document has been submitted - Philips ...
Notice: This CMS-approved document has been submitted - Philips ... Notice: This CMS-approved document has been submitted - Philips ...
CMS-1403-FC independent contractor arrangements to bring pathology services in-house and then claim that a referral is exempt from the physician self-referral prohibition because it meets the requirements of the in-office ancillary services exception or some other exception. The commenter stated that pathology is a separate physician specialty and the provision of these services is not ancillary to the provision of urology or gastroenterology. According to the commenter, pathology services provided in-office do not serve the patient’s convenience or increase access to these services as they are too time consuming and complex to perform, as the patient has always left the doctor’s office by the time the pathology examination is complete and the report issued. The commenter argued that not allowing pathology services to be protected by the in-office ancillary services exception would be consistent with the physician self-referral law and would eliminate the incentive for overutilization that currently exists. Response: For the same reasons expressed in the response to the previous comment, we are not establishing an exception to the anti-markup payment limitation, for multi-specialty groups. We also note that because we have adopted the first proposed alternative with modification, whereby the anti-markup provisions will not apply to TCs 516
CMS-1403-FC and PCs supervised or performed by a physician who performs “substantially all” of his or her professional services for the billing physician or other supplier, “hub and spoke” arrangements of multi-specialty groups should not have significant difficulty avoiding application of the anti- markup provisions. We understand the commenter’s concerns about the use of the in-office ancillary services exception and may propose rulemaking on this issue in the future. Comment: A commenter stated that dermatologic surgeons who order and read their own diagnostic tests should not be penalized for doing so by the addition of new and overly cumbersome regulations that the commenter argued are inconsistent with the existing physician self-referral law. According to the commenter, a dermatopathologist has the expertise to diagnose and monitor diseases of the skin, which entails the examination and interpretation of specially prepared tissue sections, cellular scrapings, and smears of skin lesions by means of routine and special (electron and fluorescent) microscopes. The commenter was also concerned that patient access to care in rural and underserved areas will be affected. The commenter urged that practices that order and interpret their own diagnostic tests in these areas should have the same ability to recoup the costs of equipment, space, and 517
- Page 465 and 466: CMS-1403-FC limited by the proposed
- Page 467 and 468: CMS-1403-FC Response: With respect
- Page 469 and 470: CMS-1403-FC to focus on the medical
- Page 471 and 472: CMS-1403-FC service” approach bec
- Page 473 and 474: CMS-1403-FC have the right to recei
- Page 475 and 476: CMS-1403-FC 2 approach finalized he
- Page 477 and 478: CMS-1403-FC the ordering physician
- Page 479 and 480: CMS-1403-FC ensure an adequate nexu
- Page 481 and 482: CMS-1403-FC entity” should be def
- Page 483 and 484: CMS-1403-FC between the performing
- Page 485 and 486: CMS-1403-FC supplier” to encompas
- Page 487 and 488: CMS-1403-FC to continue to provide
- Page 489 and 490: CMS-1403-FC requirements of the Alt
- Page 491 and 492: CMS-1403-FC supervised in the offic
- Page 493 and 494: CMS-1403-FC reducing access to care
- Page 495 and 496: CMS-1403-FC commenter supported ado
- Page 497 and 498: CMS-1403-FC “outside supplier,”
- Page 499 and 500: CMS-1403-FC group could recover onl
- Page 501 and 502: CMS-1403-FC incurred, thereby compe
- Page 503 and 504: CMS-1403-FC needed to provide the t
- Page 505 and 506: CMS-1403-FC performing supplier for
- Page 507 and 508: CMS-1403-FC providers, the services
- Page 509 and 510: CMS-1403-FC commenter also expresse
- Page 511 and 512: CMS-1403-FC overutilization of in-o
- Page 513 and 514: CMS-1403-FC provisions for single-s
- Page 515: CMS-1403-FC we did not propose such
- Page 519 and 520: CMS-1403-FC provisions will not app
- Page 521 and 522: CMS-1403-FC (Pub. L. 110-173) (MMSE
- Page 523 and 524: CMS-1403-FC reporting data on quali
- Page 525 and 526: CMS-1403-FC PQRI and a more detaile
- Page 527 and 528: CMS-1403-FC and our responses to th
- Page 529 and 530: CMS-1403-FC provisions of the Priva
- Page 531 and 532: CMS-1403-FC reducing eligible profe
- Page 533 and 534: CMS-1403-FC administrative or judic
- Page 535 and 536: CMS-1403-FC professionals who did n
- Page 537 and 538: CMS-1403-FC base the incentive paym
- Page 539 and 540: CMS-1403-FC A few commenters noted
- Page 541 and 542: CMS-1403-FC administrative burden t
- Page 543 and 544: CMS-1403-FC requested that more det
- Page 545 and 546: CMS-1403-FC incentive payments for
- Page 547 and 548: CMS-1403-FC December 31, 2009 and J
- Page 549 and 550: CMS-1403-FC the reporting period fo
- Page 551 and 552: CMS-1403-FC proposed to carry forwa
- Page 553 and 554: CMS-1403-FC measures group is appli
- Page 555 and 556: CMS-1403-FC measures results and nu
- Page 557 and 558: CMS-1403-FC (Delmarva Foundation fo
- Page 559 and 560: CMS-1403-FC registries to report on
- Page 561 and 562: CMS-1403-FC reporting options for r
- Page 563 and 564: CMS-1403-FC incentive payment for P
- Page 565 and 566: CMS-1403-FC to report 2009 PQRI qua
<strong>CMS</strong>-1403-FC<br />
independent contractor arrangements to bring pathology<br />
services in-house and then claim that a referral is exempt<br />
from the physician self-referral prohibition because it<br />
meets the requirements of the in-office ancillary services<br />
exception or some other exception. The commenter stated<br />
that pathology is a separate physician specialty and the<br />
provision of these services is not ancillary to the<br />
provision of urology or gastroenterology. According to the<br />
commenter, pathology services provided in-office do not<br />
serve the patient’s convenience or increase access to these<br />
services as they are too time consuming and complex to<br />
perform, as the patient <strong>has</strong> always left the doctor’s office<br />
by the time the pathology examination is complete and the<br />
report issued. The commenter argued that not allowing<br />
pathology services to be protected by the in-office<br />
ancillary services exception would be consistent with the<br />
physician self-referral law and would eliminate the<br />
incentive for overutilization that currently exists.<br />
Response: For the same reasons expressed in the<br />
response to the previous comment, we are not establishing<br />
an exception to the anti-markup payment limitation, for<br />
multi-specialty groups. We also note that because we have<br />
adopted the first proposed alternative with modification,<br />
whereby the anti-markup provisions will not apply to TCs<br />
516